Atlas Trials

A Study of CM326 in Subjects With Moderate to Severe Asthma

Clinical trial NCT05774340 · UNKNOWN

Trial details

NCT number
NCT05774340
Sponsor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Moderate to Severe Asthma
Start date
2023-05-18
Primary completion
2025-01-01
Enrollment
207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.